Faculty video in which Amin Turki introduces his work at the Clinic for Bone Marrow Transplantation and the Institute for Cell Therapeutic Research. Published by the University of Duisburg-Essen Medical Faculty for the UMEA Clinician Scientist Academy (2020).
Discussion of decision-support systems, monitoring, and risk prediction after allogeneic transplantation, including validation and regulatory challenges.
Turki discusses HARMONY Alliance work on measurable residual disease as a risk factor and possible surrogate endpoint, and distinguishes a colleague's MRD-surrogacy analysis from his genetics abstract. Do not imply first authorship of the MRD surrogacy study.